Ryan Layer, The Conversation | May 27, 2022 | 5 min read
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
The largest study of its kind identifies single nucleotide polymorphisms with disparate effects on men’s and women’s susceptibility to conditions such as bipolar disorder and schizophrenia.
Thomas Stoeger of Northwestern University has previously studied scientists’ limited focus on certain genes. In a new study, he shows how these same behaviors extend into the science of COVID-19.
Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.
Environmental engineer Gil Bohrer discusses how long-term, large-scale tracking data can shed light on the unexpected ways animals are responding to changes in the Arctic.
A new study finds reductions in greenhouse gases are insufficient to substantially slow warming, and the authors argue that to continue the benefits of reduced emissions, policymakers will need to adopt green economic recovery strategies.
By revealing that animals could develop immune responses against their own tissues, the physician-scientist established an entirely new field of science.
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
